Oral anticoagulant use after catheter ablation for atrial fibrillation based on thrombo-embolic risk: future studies will be needed for bleeding high-risk group

European Heart Journal

2 July 2024
Organised by: Logo
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY CARDIOVASCULAR PHARMACOLOGY Atrial Fibrillation (AF)

Contributors

Yoshitaka Iwanaga
Yoshitaka Iwanaga

Author

National Cerebral & Cardiovascular Center Suita , Japan

ESC 365 is supported by